Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FATZN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,808
Award facts
- Contract value 100% obligated
- $5,808.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $5,808.14 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating the award was made through unrestricted federal procurement competition. The place of performance is listed as Conshohocken, Pennsylvania.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the military pharmaceutical supply chain, with no subcontractors identified in this transaction.
Quick answers
Who was awarded contract SPE2DB26FATZN?
SPE2DB26FATZN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DB26FATZN worth?
The government has obligated $5,808 on SPE2DB26FATZN.
Is contract SPE2DB26FATZN an order under another contract?
Yes. SPE2DB26FATZN is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATZN competed?
The extent of competition for SPE2DB26FATZN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award